China NT Pharma Group Company Ltd (1011.HK)
0.78HKD
14 Jun 2019
HK$0.01 (+1.30%)
HK$0.77
HK$0.78
HK$0.80
HK$0.77
952,000
2,088,231
HK$2.01
HK$0.54
Latest Key Developments (Source: Significant Developments)
China NT Pharma Group Co Posts FY Loss Attributable Rmb957.7 Mln
March 29 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::FY LOSS ATTRIBUTABLE RMB957.7 MILLION VERSUS PROFIT OF RMB165.2 MILLION.FY REVENUE FROM CONTINUING OPERATIONS RMB571.5 MILLION VERSUS RMB604.8 MILLION. Full Article
China NT Pharma Group Announces Termination Of Letter Of Intent In Relation To Possible Disposal
March 1 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::UPDATES ON UNIT'S PROPOSED DISPOSAL OF CERTAIN STAKE IN SUZHOU FIRST PHARMACEUTICAL TO BROTHER ENTERPRISES.ANNOUNCES TERMINATION OF LETTER OF INTENT IN RELATION TO A POSSIBLE DISPOSAL AS BOTH PARTIES FAILED TO REACH AN AGREEMENT. Full Article
China NT Pharma Group Co Announces Placing Of Up To Hk$100 MLN Bonds
Jan 25 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::ANNOUNCES PLACING OF UP TO HK$100 MILLION BONDS.ISSUE PRICE REPRESENTS 100% OF PRINCIPAL AMOUNT OF BONDS. Full Article
China NT Pharma Group Co Posts HY Profit Attributable RMB82.9 Mln
Aug 21 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::HY REVENUE FROM CONTINUING OPERATIONS RMB312 MILLION VERSUS RMB314.4 MILLION.HY PROFIT ATTRIBUTABLE RMB82.9 MILLION VERSUS RMB80.7 MILLION. Full Article
China NT Pharma Group Co Appoints Wang Fei As CFO
April 6 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::CHIU YU KANG RESIGNED AS CHIEF FINANCIAL OFFICER.APPOINTS WANG FEI AS CFO. Full Article
China NT Pharma Group Co says HY profit attributable to equity shareholders up 61.1 pct
Aug 21 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::HY profit attributable to equity shareholders of company increased by 61.1% from RMB50.1 million to RMB80.7 million.HY overall revenue of group up 44.9 percent to RMB559.1 million. Full Article
Earnings vs. 
Estimates